-- James Edgemond, CFO and Treasurer, on April 09, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,778,922. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000163617826000008/xslF345X05/primarydocument.xml